Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Riccardo Perfetti. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Riccardo Perfetti har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:APLT / Applied Therapeutics, Inc. | Chief Medical Officer | 890 409 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Riccardo Perfetti. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp APLT / Applied Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i APLT / Applied Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i APLT / Applied Therapeutics, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Riccardo Perfetti som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-06 |
|
4 | APLT |
Applied Therapeutics, Inc.
Common Stock |
S - Sale | −10 366 | 890 409 | −1,15 | 0,44 | −4 561 | 391 780 | |
2025-02-07 |
|
4 | APLT |
Applied Therapeutics, Inc.
Common Stock |
S - Sale | −86 078 | 900 775 | −8,72 | 0,61 | −52 508 | 549 473 | |
2024-08-23 |
|
4 | APLT |
Applied Therapeutics, Inc.
Common Stock |
S - Sale | −22 681 | 986 853 | −2,25 | 5,83 | −132 230 | 5 753 353 | |
2024-06-10 |
|
4 | APLT |
Applied Therapeutics, Inc.
Common Stock |
S - Sale | −22 003 | 1 009 534 | −2,13 | 4,32 | −95 053 | 4 361 187 | |
2024-03-18 |
|
4 | APLT |
Applied Therapeutics, Inc.
Common Stock |
S - Sale | −110 804 | 1 031 537 | −9,70 | 5,39 | −597 234 | 5 559 984 | |
2023-12-22 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
A - Award | 450 000 | 1 142 341 | 65,00 | ||||
2023-12-01 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | −1 583 | 692 341 | −0,23 | 1,97 | −3 119 | 1 363 912 | |
2023-09-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | −10 932 | 693 924 | −1,55 | 2,70 | −29 516 | 1 873 595 | |
2023-01-13 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
A - Award | 550 000 | 704 856 | 355,17 | ||||
2023-01-13 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | −6 053 | 154 856 | −3,76 | 0,91 | −5 508 | 140 919 | |
2022-04-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Employee Stock Option (Right to Buy) |
A - Award | 50 000 | 50 000 | |||||
2022-03-23 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
P - Purchase | 30 000 | 160 909 | 22,92 | 1,97 | 59 100 | 316 991 | |
2022-03-23 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
P - Purchase | 21 961 | 130 909 | 20,16 | 1,98 | 43 483 | 259 200 | |
2022-03-23 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
P - Purchase | 12 548 | 108 948 | 13,02 | 1,85 | 23 214 | 201 554 | |
2022-01-11 |
|
4/A | APLT |
Applied Therapeutics Inc.
Common Stock |
A - Award | 48 200 | 48 200 | |||||
2022-01-11 |
|
4 | APLT |
Applied Therapeutics Inc.
Employee Stock Option (Right to Buy) |
A - Award | 32 100 | 32 100 | |||||
2022-01-11 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
A - Award | 48 200 | 96 400 | 100,00 | ||||
2021-12-16 |
|
4 | APLT |
Applied Therapeutics Inc.
Employee Stock Option (Right to Buy) |
A - Award | 32 100 | 32 100 | |||||
2021-12-16 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
A - Award | 48 200 | 48 200 | |||||
2021-08-11 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −8 873 | 94 874 | −8,55 | |||
2021-08-11 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −800 | 0 | −100,00 | 16,35 | −13 080 | |
2021-08-11 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | 8 273 | 600 | −107,82 | 15,85 | 131 127 | 9 510 |
2021-08-11 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | −8 873 | 8 873 | −50,00 | 1,44 | −12 777 | 12 777 |
2021-08-11 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 103 747 | −12,63 | |||
2021-08-11 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −4 700 | 0 | −100,00 | 17,85 | −83 895 | |
2021-08-11 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −10 300 | 4 700 | −68,67 | 17,18 | −176 954 | 80 746 |
2021-08-11 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 1,44 | 21 600 | 21 600 | |
2021-07-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 118 747 | −11,22 | |||
2021-07-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 17,18 | −257 700 | |
2021-07-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 1,44 | 21 600 | 21 600 | |
2021-07-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 133 747 | −10,08 | |||
2021-07-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 17,50 | −262 500 | |
2021-07-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 1,44 | 21 600 | 21 600 | |
2021-07-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 148 747 | −9,16 | |||
2021-07-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −7 224 | 0 | −100,00 | 17,39 | −125 625 | |
2021-07-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −7 776 | 7 224 | −51,84 | 17,05 | −132 581 | 123 169 |
2021-07-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 1,44 | 21 600 | 21 600 | |
2021-07-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −460 | 163 747 | −0,28 | |||
2021-07-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −460 | 0 | −100,00 | 19,54 | −8 988 | |
2021-07-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 460 | 460 | 1,44 | 662 | 662 | |
2021-07-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −460 | 164 207 | −0,28 | |||
2021-07-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −460 | 0 | −100,00 | 20,51 | −9 435 | |
2021-07-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | −460 | 460 | −50,00 | 1,44 | −662 | 662 |
2021-07-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −460 | 164 667 | −0,28 | |||
2021-07-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −460 | 0 | −100,00 | 21,25 | −9 775 | |
2021-07-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 460 | 460 | 1,44 | 662 | 662 | |
2021-06-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −460 | 165 127 | −0,28 | |||
2021-06-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −300 | 0 | −100,00 | 21,71 | −6 513 | |
2021-06-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −160 | 300 | −34,78 | 20,80 | −3 328 | 6 240 |
2021-06-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 460 | 460 | 1,44 | 662 | 662 | |
2021-06-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −460 | 165 587 | −0,28 | |||
2021-06-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −460 | 0 | −100,00 | 21,76 | −10 010 | |
2021-06-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 460 | 460 | 1,44 | 662 | 662 | |
2021-06-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −3 547 | 166 047 | −2,09 | |||
2021-06-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −1 200 | 0 | −100,00 | 24,01 | −28 812 | |
2021-06-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −1 987 | 1 200 | −62,35 | 23,51 | −46 714 | 28 212 |
2021-06-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −360 | 3 187 | −10,15 | 21,96 | −7 906 | 69 987 |
2021-06-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 3 547 | 3 547 | 1,44 | 5 108 | 5 108 | |
2021-06-07 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −260 | 0 | −100,00 | 21,38 | −5 559 | |
2021-06-07 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −200 | 260 | −43,48 | 20,43 | −4 086 | 5 312 |
2021-06-07 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 460 | 460 | 1,44 | 662 | 662 | |
2021-06-07 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −460 | 170 054 | −0,27 | |||
2021-06-07 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −460 | 0 | −100,00 | 19,65 | −9 039 | |
2021-06-07 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 460 | 460 | 1,44 | 662 | 662 | |
2021-06-07 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −460 | 170 514 | −0,27 | |||
2021-06-07 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −460 | 0 | −100,00 | 19,66 | −9 044 | |
2021-06-07 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 460 | 460 | 1,44 | 662 | 662 | |
2021-06-07 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −460 | 169 594 | −0,27 | |||
2021-05-26 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −460 | 170 974 | −0,27 | |||
2021-05-26 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −460 | 0 | −100,00 | 19,43 | −8 938 | |
2021-05-26 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 460 | 460 | 1,44 | 662 | 662 | |
2021-05-26 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −460 | 171 434 | −0,27 | |||
2021-05-26 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −460 | 0 | −100,00 | 17,97 | −8 266 | |
2021-05-26 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 460 | 460 | 1,44 | 662 | 662 | |
2021-05-26 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 640 | 171 894 | −0,95 | |||
2021-05-26 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −1 640 | 0 | −100,00 | 17,25 | −28 290 | |
2021-05-26 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 1 640 | 1 640 | 1,44 | 2 362 | 2 362 | |
2021-05-13 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −200 | 173 534 | −0,12 | |||
2021-05-13 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 17,27 | −3 454 | |
2021-05-13 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 200 | 200 | 1,44 | 288 | 288 | |
2021-04-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −400 | 173 734 | −0,23 | |||
2021-04-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −460 | 0 | −100,00 | 18,32 | −8 427 | |
2021-04-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 460 | 460 | 1,44 | 662 | 662 | |
2021-04-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −400 | 174 194 | −0,23 | |||
2021-04-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −460 | 0 | −100,00 | 18,28 | −8 409 | |
2021-04-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 460 | 460 | 1,44 | 662 | 662 | |
2021-04-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 640 | 174 654 | −0,93 | |||
2021-04-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −300 | 0 | −100,00 | 18,92 | −5 676 | |
2021-04-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −1 340 | 300 | −81,71 | 18,33 | −24 562 | 5 499 |
2021-04-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 1 640 | 1 640 | 1,44 | 2 362 | 2 362 | |
2021-04-16 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −200 | 176 294 | −0,11 | |||
2021-04-16 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 17,11 | −3 422 | |
2021-04-16 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 200 | 200 | 1,44 | 288 | 288 | |
2021-03-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −460 | 176 494 | −0,26 | |||
2021-03-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −460 | 0 | −100,00 | 18,43 | −8 478 | |
2021-03-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 460 | 460 | 1,44 | 662 | 662 | |
2021-03-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 176 954 | −0,26 | |||
2021-03-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 18,53 | −8 616 | |
2021-03-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2021-03-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 177 419 | −0,26 | |||
2021-03-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 19,68 | −9 151 | |
2021-03-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2021-03-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 177 884 | −0,26 | |||
2021-03-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 19,61 | −9 119 | |
2021-03-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2021-03-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 178 349 | −0,26 | |||
2021-03-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 19,38 | −9 012 | |
2021-03-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2021-03-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 178 814 | −0,26 | |||
2021-03-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 18,48 | −8 593 | |
2021-03-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2021-02-25 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 295 | 179 279 | −0,72 | |||
2021-02-25 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −1 295 | 0 | −100,00 | 23,20 | −30 044 | |
2021-02-25 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 1 295 | 1 295 | 1,44 | 1 865 | 1 865 | |
2021-02-25 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 125 | 180 574 | −1,16 | |||
2021-02-25 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −600 | 0 | −100,00 | 24,57 | −14 742 | |
2021-02-25 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −1 525 | 600 | −71,76 | 23,71 | −36 158 | 14 226 |
2021-02-25 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 2 125 | 2 125 | 1,44 | 3 060 | 3 060 | |
2021-02-25 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 182 669 | −0,25 | |||
2021-02-25 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 21,84 | −10 156 | |
2021-02-25 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy |
M - Exercise | X | −1 295 | 183 164 | −0,70 | |||
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −600 | 0 | −100,00 | 27,30 | −16 380 | |
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −695 | 600 | −53,67 | 26,35 | −18 313 | 15 810 |
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 1 295 | 1 295 | 1,44 | 1 865 | 1 865 | |
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy |
M - Exercise | X | −1 295 | 184 459 | −0,70 | |||
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −595 | 0 | −100,00 | 27,77 | −16 523 | |
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −700 | 595 | −54,05 | 26,87 | −18 809 | 15 988 |
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 1 295 | 1 295 | 1,44 | 1 865 | 1 865 | |
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −3 785 | 185 754 | −2,00 | |||
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −660 | 0 | −100,00 | 26,43 | −17 444 | |
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | 2 325 | 660 | −139,64 | 25,47 | 59 218 | 16 810 |
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −800 | 2 985 | −21,14 | 24,36 | −19 488 | 72 715 |
2021-02-03 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 3 785 | 3 785 | 1,44 | 5 450 | 5 450 | |
2021-01-21 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy |
M - Exercise | X | −465 | 189 539 | −0,24 | |||
2021-01-21 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 20,30 | −9 440 | |
2021-01-21 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2021-01-21 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy |
M - Exercise | X | −465 | 189 004 | −0,25 | |||
2021-01-21 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 21,08 | −9 802 | |
2021-01-21 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2021-01-21 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 189 469 | −0,24 | |||
2021-01-21 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 21,83 | −10 151 | |
2021-01-21 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2021-01-08 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy |
M - Exercise | X | −7 985 | 189 934 | −4,03 | |||
2021-01-08 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −7 685 | 0 | −100,00 | 23,18 | −178 138 | |
2021-01-08 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −300 | 7 685 | −3,76 | 21,92 | −6 576 | 168 455 |
2021-01-08 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 7 985 | 7 985 | 1,44 | 11 498 | 11 498 | |
2021-01-08 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy |
M - Exercise | X | −765 | 197 919 | −0,39 | |||
2021-01-08 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −765 | 0 | −100,00 | 21,88 | −16 738 | |
2021-01-08 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 765 | 765 | 1,44 | 1 102 | 1 102 | |
2021-01-08 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −7 765 | 198 684 | −3,76 | |||
2021-01-08 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −7 600 | 0 | −100,00 | 23,50 | −178 600 | |
2021-01-08 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −165 | 7 600 | −2,12 | 22,17 | −3 658 | 168 492 |
2021-01-08 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 7 765 | 7 765 | 1,44 | 11 182 | 11 182 | |
2020-12-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy |
M - Exercise | X | −465 | 206 449 | −0,22 | |||
2020-12-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −65 | 0 | −100,00 | 21,67 | −1 409 | |
2020-12-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −400 | 65 | −86,02 | 20,97 | −8 388 | 1 363 |
2020-12-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2020-12-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy |
M - Exercise | X | −465 | 206 914 | −0,22 | |||
2020-12-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 21,95 | −10 207 | |
2020-12-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2020-12-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 207 379 | −0,22 | |||
2020-12-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 21,81 | −10 142 | |
2020-12-30 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2020-12-14 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
A - Award | 92 200 | 92 200 | |||||
2020-12-09 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 207 844 | −0,22 | |||
2020-12-09 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 20,46 | −9 514 | |
2020-12-09 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | −465 | 465 | −50,00 | 1,44 | −670 | 670 |
2020-12-09 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 208 309 | −0,22 | |||
2020-12-09 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 19,98 | −9 291 | |
2020-12-09 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | −465 | 465 | −50,00 | 1,44 | −670 | 670 |
2020-12-09 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 208 774 | −0,22 | |||
2020-12-09 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 20,49 | −9 528 | |
2020-12-09 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2020-11-24 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 209 239 | −0,22 | |||
2020-11-24 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 21,62 | −10 053 | |
2020-11-24 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | −465 | 465 | −50,00 | 1,44 | −670 | 670 |
2020-11-24 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 209 704 | −0,22 | |||
2020-11-24 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 20,59 | −9 574 | |
2020-11-24 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | −465 | 465 | −50,00 | 1,44 | −670 | 670 |
2020-11-24 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 660 | 210 169 | −0,78 | |||
2020-11-24 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −760 | 0 | −100,00 | 19,54 | −14 850 | |
2020-11-24 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −900 | 760 | −54,22 | 18,68 | −16 812 | 14 197 |
2020-11-24 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 1 660 | 1 660 | 1,44 | 2 390 | 2 390 | |
2020-11-12 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −200 | 211 829 | −0,09 | |||
2020-11-12 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 17,59 | −3 518 | |
2020-11-12 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 200 | 200 | 1,44 | 288 | 288 | |
2020-10-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 212 029 | −0,22 | |||
2020-10-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 17,27 | −8 031 | |
2020-10-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2020-10-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 212 494 | −0,22 | |||
2020-10-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 18,49 | −8 598 | |
2020-10-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2020-10-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −465 | 212 959 | −0,22 | |||
2020-10-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
S - Sale | X | −465 | 0 | −100,00 | 21,20 | −9 858 | |
2020-10-29 |
|
4 | APLT |
Applied Therapeutics Inc.
Common Stock |
M - Exercise | X | 465 | 465 | 1,44 | 670 | 670 | |
2019-12-18 |
|
4 | APLT |
Applied Therapeutics Inc.
Employee Stock Option (right to buy) |
A - Award | 80 000 | 80 000 | |||||
2019-05-15 |
|
4 | APLT |
Applied Therapeutics Inc.
Employee Stock Option (right to buy) |
A - Award | 170 522 | 170 522 |